NPI registry status
Active
2026 NPPES data Neurology Physician NPI 1225146350 M.D.
Verify on CMS → Jullius Ancheta, M.D.
Neurology Physician in Venice, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 19,866 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 454 beneficiaries · Neurology Physician avg: 1K
MIPS score
79.2/100
▼ 4 pts below national avg 83.1 · Above neutral
Industry payments
$745.35
38 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Jullius Ancheta, M.D. reported a CMS MIPS final score of 79.2/100 - below the 83.1 national average - and filed 2,165 Medicare Part D claims in 2023.
- 79.2/100
- MIPS score · -4 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jullius Ancheta, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
79 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jullius Ancheta, M.D. sits
This provider among neurology physician peers
Across the 5,437 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jullius Ancheta, M.D. writes more Part D claims than 72% of them and scores higher on MIPS quality than 37% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Jullius Ancheta, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jullius Ancheta, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jullius Ancheta, M.D.?
Near national averagePrimary specialty
Neurology Physician
Medicare Part D claims
2,165 65% vs specialty avg
MIPS final score
79.2/100 3.9 pts vs avg
Specialty distribution in Florida
How Neurology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Jullius Ancheta, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 79.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurology Physician) - 79.2/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jullius Ancheta, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 517 RIVIERA ST, Venice, FL, 34285, with a listed phone of (941) 412-1208. NPI 1225146350 was issued on 08/28/2006.
Medicare Part D records for calendar year 2023 show 2,165 prescription claims written by this provider, covering 454 Medicare beneficiaries and totaling roughly $1.1 million in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.2/100 for the 2023 performance year (Quality 55.3), compared with the national average of 83.1.
Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225146350 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/28/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.1639
Final Score
Avg: 83.1
55.323
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jullius Ancheta, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$745
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Jullius Ancheta, M.D.. To verify Jullius Ancheta, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,165
Total Claims
$1.1M
Total Drug Cost
454
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,471
- Total Day Supply
- 132,090
- Generic Drug Cost
- $77K
Patient Demographics
- Average Patient Age
- 75.5 years
- Avg HCC Risk Score
- 1.64
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 33, 65-74: 151, 75-84: 202, 85+: 68
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jullius Ancheta, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
246 claims
- Levetiracetam
Levetiracetam
188 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
176 claims
- Primidone
Primidone
129 claims
- Donepezil Hcl
Donepezil Hcl
123 claims
- Oxcarbazepine 88
Oxcarbazepine
88 claims
- Topiramate 88
Topiramate
88 claims
- Memantine Hcl 73
Memantine Hcl
73 claims
| Drug | Claims |
|---|---|
| Gabapentin | 246 |
| Levetiracetam | 188 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 176 |
| Primidone | 129 |
| Donepezil Hcl | 123 |
| Oxcarbazepine | 88 |
| Topiramate | 88 |
| Memantine Hcl | 73 |
| Duloxetine Hcl | 48 |
| Lamotrigine | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Jullius Ancheta, M.D. fits within the Neurology Physician landscape nationally.
19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider
Jullius Ancheta, M.D.'s 2,165 claims are above the specialty average of 1,309.
Nearby Neurology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Ancheta.
Dr. David Abarbanel
MD
Jacksonville, FL
Hamidreza Abbasi
Fort Myers, FL
Dr. Fariha Abbasi-Feinberg
MD
Fort Myers, FL
Dr. Hermelinda Abcede
MD
Fort Myers, FL
Dr. Noureldin Abdelhamid
M.D.
Hollywood, FL
Compare Neurology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Jullius Ancheta, M.D.'s specialty? ▼
Jullius Ancheta, M.D. specializes in Neurology Physician and practices in Venice, Florida. Credentials: M.D..
How much does Jullius Ancheta, M.D. prescribe under Medicare Part D? ▼
In 2023, Jullius Ancheta, M.D. wrote 2,165 Medicare Part D claims totaling $1.1M in drug costs for 454 beneficiaries.
What is Jullius Ancheta, M.D.'s Medicare quality score? ▼
Jullius Ancheta, M.D. has a CMS MIPS Final Score of 79.2/100 (Quality: 55.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jullius Ancheta, M.D. located? ▼
Jullius Ancheta, M.D. is located at 517 RIVIERA ST, Venice, FL, 34285. Phone: (941) 412-1208.
What is Jullius Ancheta, M.D.'s NPI number? ▼
Jullius Ancheta, M.D.'s National Provider Identifier (NPI) is 1225146350, issued on 08/28/2006.
How many Neurology Physician providers are there in the US? ▼
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does Jullius Ancheta, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Jullius Ancheta, M.D.'s most frequently prescribed drugs include Gabapentin, Levetiracetam, Carbidopa-Levodopa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jullius Ancheta, M.D. accept Medicare? ▼
Jullius Ancheta, M.D. appears in CMS Medicare data with 2,165 Part D claims and 454 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jullius Ancheta, M.D.'s credentials? ▼
Jullius Ancheta, M.D.'s NPI is 1225146350 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.